KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 160 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $14,000 | -12.5% | 2,619 | +7.2% | 0.00% | – |
Q2 2016 | $16,000 | +45.5% | 2,443 | +2.1% | 0.00% | – |
Q1 2016 | $11,000 | 0.0% | 2,392 | +8.5% | 0.00% | – |
Q4 2015 | $11,000 | +57.1% | 2,205 | +5.9% | 0.00% | – |
Q3 2015 | $7,000 | -77.4% | 2,083 | -32.6% | 0.00% | – |
Q2 2015 | $31,000 | -86.3% | 3,089 | -82.6% | 0.00% | -100.0% |
Q1 2015 | $226,000 | -96.2% | 17,750 | -95.8% | 0.00% | -95.5% |
Q4 2014 | $5,937,000 | – | 419,575 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |